Clinical Trials Browser

Phase 1/2 × UNKNOWN × Carcinoma, Squamous Cell × Clear all

NCT03636685 2018-08-17

Study of Anlotinib Plus Chemotherapy as the First-line Treatment in Patients With Advanced NSCLC

Phase 1/2 Unknown

Adenocarcinoma, Carcinoma, Squamous Cell